Showing 3151-3160 of 23149 results for "".
FAQ: Automated Vitrification and Improved Pregnancy Rates
https://reachmd.com/programs/global-womens-health-academy/faq-automated-vitrification-and-improved-pregnancy-rates/9764/Dr. Alla Kalugina answers questions for the Global Women's Health Academy.The Rise of Specialist-Driven Alternative Payment Models in American Medicine
https://reachmd.com/programs/perspectives-ama/rise-specialist-driven-alternative-payment-models-american-medicine/8241/Dr. Lawrence Kosinski, founder and Chief Medical Officer for SonarMD, discusses the critical emergence of specialist-driven APM platforms.All Things Educational: A Panel Discusses Independent CME, The Sunshine Act, and Reporting
https://reachmd.com/programs/voices-from-american-medicine/all-things-educational-panel-discusses-independent-cme-sunshine-act-reporting/7901/There has been ongoing dialogue about the guidance needed to provide clarity on the reporting of indepedent medical education payments and the Sunshine Act. In this discussion, expert panelists analyze the definition of indirect payments and their exclusion as applied to CME-related payments and traResolving Disruptive Physician Behavior
https://reachmd.com/programs/clinicians-roundtable/resolving-disruptive-physician-behavior/3555/Disruptive physician behavior is often tolerated until a crisis emerges which then triggers disciplinary action. How else might we handle this delicate situation? William Swiggart, the co-director for the Center for Professional Health at Vanderbilt University Medical Center, joins host Dr. LeslieBridges To Excellence: Physician Office Link
https://reachmd.com/programs/clinicians-roundtable/bridges-to-excellence-physician-office-link/2806/Bridges to Excellence (BTE) is a national not-for-profit organization that designs and implements programs to recognize and reward physicians that deliver high quality care. In talking with BTE’s CEO, Francios de Brantes, host Dr. Bill Rutenberg learns about BTE’s methodology for measuring quality,Closing Gaps in CRC Screening: Patient-Centered Strategies
https://reachmd.com/programs/on-the-frontlines-of-colorectal-cancer/gaps-crc-screening-patient-centered/49176/Colorectal cancer screening significantly reduces both incidence and mortality, yet screening gaps persist. In this conversation with Ryan Quigley, Dr. Peter Buch reviews key barriers to screening, including patient perceptions, access challenges, and cultural factors, and highlights how expFrom Image to Intervention: Integrating the Diagnosis into Specialty Lens Designs and Corneal Rehabilitation
https://reachmd.com/programs/empower/from-image-to-intervention-integrating-the-diagnosis-into-specialty-lens-designs-and-corneal-rehabilitation/39289/How to keep patients informed across the continuum of care.The Cost of Progress: Examining Barriers to ATTR-CM Care
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/the-cost-of-progress-examining-barriers-to-attr-cm-care/39315/With three landmark therapies reshaping transthyretin amyloid cardiomyopathy (ATTR-CM) care, patient outcomes have been significantly improved. However, the recent advancements are accompanied by equity and accessibility challenges, particularly when it comes to navigating insurance barriers. Dr. MiInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to disActive Surveillance of Prostate Cancer: Evaluating Long-Term Outcomes
https://reachmd.com/programs/frontlines-prostate-cancer/active-surveillance-of-prostate-cancer-evaluating-long-term-outcomes/32223/While overtreatment of favorable-risk prostate cancer remains a pressing challenge, undertreatment of aggressive disease is also a dangerous possibility. A multicenter study addresses that gap with 10-year follow-up data on patients using protocol-directed active surveillance. Join Dr. Lisa Newcomb,